The Effect of Intravenous Lidocaine on Pain After Lumbar Spinal Fusion

Sponsor
Chung-Ang University Hosptial, Chung-Ang University College of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT01319682
Collaborator
(none)
54
1
2
23.1
2.3

Study Details

Study Description

Brief Summary

This prospective randomized study aims to evaluate the effectiveness of intravenous lidocaine injection on the relief of pain in patients undergoing 1-level posterior lumbar fusion.

A total of 54 patients will be randomized into one of two groups (group C or group I) based on Excel number generation.

Patients in group C will receive received normal saline intravenous injection, and patients in group I will receive an intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous lidocaine infusion of 2 mg/kg/hr.

Visual analogue scale pain scores, fentanyl consumption and the frequency at which patients pushed the button (FPB) of a patient-controlled analgesia system will be recorded at 4, 12, 24, 48 hours postoperatively.

Condition or Disease Intervention/Treatment Phase
  • Drug: Intravenous lidocaine injection
  • Drug: Intravenous normal saline injection
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Intravenous Lidocaine for Effective Pain Relief After Posterior Lumbar Spinal Fusion: a Prospective, Randomized, Double-blind, Placebo-controlled Study
Study Start Date :
Mar 1, 2011
Actual Primary Completion Date :
Feb 1, 2013
Actual Study Completion Date :
Feb 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intravenous lidocaine injection group

Patients in Group I (intravenous lidocaine injection group) received an intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous lidocaine infusion of 2 mg/kg/hr.

Drug: Intravenous lidocaine injection
Patients in Group I (intravenous lidocaine injection group) received an intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous lidocaine infusion of 2 mg/kg/hr.
Other Names:
  • IV lidocaine
  • Placebo Comparator: Placebo control group

    Patients in Group C (placebo control group) received normal saline intravenous injection

    Drug: Intravenous normal saline injection
    The patients in Group C (placebo control group) received normal saline intravenous injection
    Other Names:
  • IV saline
  • Outcome Measures

    Primary Outcome Measures

    1. Postopeartive pain measured using Visual analogue scale at postoperative 4hour [post op 4hour]

      Patients will be assessed for pain using a visual analogue pain scale (VAS). It is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end; left side end which represents 0 is 'No pain', right side end with 100 is 'Very severe pain'. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks. To check the severity of pain VAS will be measured at post op 4hour.

    Secondary Outcome Measures

    1. visual analogue scale 12 hour [Post op 12 hour]

      Patients will be assessed for pain using a visual analogue pain scale (VAS). It is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end; left side end which represents 0 is 'No pain', right side end with 100 is 'Very severe pain'. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks. To check the severity of pain VAS will be measured at post op 12 hour.

    2. visual analogue scale 24hour [Post op 24 hour]

      Patients will be assessed for pain using a visual analogue pain scale (VAS). It is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end; left side end which represents 0 is 'No pain', right side end with 100 is 'Very severe pain'. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks. To check the severity of pain VAS will be measured at post op 24 hour.

    3. Visual analogue scale 48hour [Post Op 48hour]

      Patients will be assessed for pain using a visual analogue pain scale (VAS). It is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end; left side end which represents 0 is 'No pain', right side end with 100 is 'Very severe pain'. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks. To check the severity of pain VAS will be measured at post op 48 hour.

    4. Opioid consumption 4hour [Post Op 4hour]

      The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. In the case of persistent pain greater than a visual analogue scale (VAS) pain score of 30 mm, an additional 50 μg of fentanyl will be injected intra-venously by nursing staff until the pain was relieved to a level less than a VAS pain score of 30 mm. And sum of delivery from PCA system and additional opioid fom immediately after operation to post op 4hour will be measured.

    5. Opioid consumption 24hour [Post op 24 hour]

      The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. In the case of persistent pain greater than a visual analogue scale (VAS) pain score of 30 mm, an additional 50 μg of fentanyl will be injected intra-venously by nursing staff until the pain was relieved to a level less than a VAS pain score of 30 mm. And sum of delivery from PCA system and additional opioid from 12 hour to post op 24 hour will be measured.

    6. Opioid consumption 12 hour [Post Op 12 hour]

      The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. In the case of persistent pain greater than a visual analogue scale (VAS) pain score of 30 mm, an additional 50 μg of fentanyl will be injected intra-venously by nursing staff until the pain was relieved to a level less than a VAS pain score of 30 mm. And sum of delivery from PCA system and additional opioid from post op 4hour to post op 12 hour will be measured.

    7. Opioid consumption 48hour [Post Op 48 hour]

      The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. In the case of persistent pain greater than a visual analogue scale (VAS) pain score of 30 mm, an additional 50 μg of fentanyl will be injected intra-venously by nursing staff until the pain was relieved to a level less than a VAS pain score of 30 mm. And sum of delivery from PCA system and additional opioid from post op 24 hour to post op 48 hour will be measured

    8. FPB 4 hour [Post Op 4 hour]

      The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. And total frequency of patient to push the button of the PCA machine (FPB) fom immediately after operation to post op 4 hour will be measured.

    9. FPB 12 hour [post op 12 hour]

      The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. And frequency of patient to push the button of the PCA machine (FPB) from post op 4 hour to post op 12 hour will be measured.

    10. FPB 24 hour [Post Op 24 hour]

      The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. And frequency of patient to push the button of the PCA machine (FPB) fom post op 12 hour to post op 24 hour will be measured.

    11. FPB 48 hour [Post Op 48 hour]

      The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. And frequency of patient to push the button of the PCA machine (FPB) fom post op 24 hour to post op 48 hour will be measured.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 1-level posterior lumbar fusion
    Exclusion Criteria:
    • mental change

    • allergy to local anesthetics

    • chronic analgesics user

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 ChungAng University Seoul Korea, Republic of

    Sponsors and Collaborators

    • Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    Investigators

    • Study Chair: Hyun Kang, Ph.D.,, Chung-Ang University Hosptial, Chung-Ang University College of Medicine
    • Study Director: Young-Baeg Kim, Ph.D., Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hyun Kang, Assistant professor, Chung-Ang University Hosptial, Chung-Ang University College of Medicine
    ClinicalTrials.gov Identifier:
    NCT01319682
    Other Study ID Numbers:
    • ChungAngUH2
    First Posted:
    Mar 22, 2011
    Last Update Posted:
    Aug 2, 2013
    Last Verified:
    Mar 1, 2011
    Keywords provided by Hyun Kang, Assistant professor, Chung-Ang University Hosptial, Chung-Ang University College of Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 2, 2013